Efficacy and Safety of Anrikefon Injection for the Treatment of Postoperative Pain in Patients Undergoing Laparoscopic Hepatectomy

Phase 2 Not yet recruiting 108 enrolled Tianjin Medical University Cancer Institute and Hospital

RandomizedParallel-groupOpen-labelTreatment

Summary

Efficacy and safety of Anrikefon injection for the treatment of postoperative pain in patients undergoing laparoscopic hepatectomy--A single-center, randomized, controlled clinical study

Timeline

Start: 2026-09
Primary completion: 2027-12
Completion: 2027-12

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Anrikefon	Unknown	—	—
Comparator	Flurbiprofen	Small molecule	—	Intravenous

Indications

No indication recorded.